70 results
8-K
QSI
Quantum-Si Incorporated - Ordinary Shares
30 May 24
Chuck Kummeth, to serve as independent Chairman of the Board of Directors
4:27pm
with his executive leadership experience in the biomedical and life sciences industries.
The Board has affirmatively determined that Mr. Kummeth
8-K
EX-99.1
QSI
Quantum-Si Incorporated - Ordinary Shares
30 May 24
Chuck Kummeth, to serve as independent Chairman of the Board of Directors
4:27pm
. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During Mr. Kummeth’s tenure at Bio … . Kummeth’s leadership, Bio-Techne’s market capitalization grew from $2.2B to a high of $21B, culminating in an invitation for the company to join the S&P 500
8-K
EX-99.1
QSI
Quantum-Si Incorporated - Ordinary Shares
9 May 24
Quantum-Si Reports First Quarter 2024 Financial Results
4:12pm
ongoing leadership transitions; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost
DEFR14A
QSI
Quantum-Si Incorporated - Ordinary Shares
29 Apr 24
Revised proxy
8:16pm
the rapid global growth of next generation sequencing into new and emerging markets. Prior to that, Mr. Hawkins held several senior leadership roles … . Mr. Hawkins’ qualifications to serve on our board of directors include his significant leadership experience and his background in life sciences
8-K
EX-99.1
QSI
Quantum-Si Incorporated - Ordinary Shares
9 Apr 24
Corporate Presentation April 2024
5:10pm
leadership transitions; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost … Successfully executed controlled launch generating $1.1M in revenue Built a world class leadership team Transformed organization from research into commercial
8-K
130r 8za2
21 Mar 24
Departure of Directors or Certain Officers
4:14pm
8-K
EX-99.1
buoaw3l
21 Mar 24
Departure of Directors or Certain Officers
4:14pm
8-K
EX-99.1
65y8ebj 3tdj6
29 Feb 24
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
4:16pm
8-K
EX-99.1
t3q1uuw6
5 Feb 24
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
8:09am
8-K
EX-99.1
9isqgd3p6cab3n9ja
9 Nov 23
Quantum-Si Reports Third Quarter 2023 Financial Results
4:21pm
8-K
EX-99.1
byj0049qpgks
21 Sep 23
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
8:15am
S-3
roehoyq5mq7dy
11 Aug 23
Shelf registration
4:27pm
8-K
EX-99.1
84y5k9upbs5a
7 Aug 23
Quantum-Si Reports Second Quarter 2023 Financial Results
8:17am
8-K
EX-99.1
tluuwxhe 445xcl
21 Jun 23
Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations
8:35am
8-K
EX-99.1
0fj1rzmb3
22 May 23
Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors
8:26am